© 2020 – 2023 AEA3 WEB | AEAƎ United Kingdom News
AEA3 WEB | AEAƎ United Kingdom News
News

FDA approves breakthrough Alzheimer’s drug Lecanemab

Drug works with the body’s immune system to clear amyloid protein buildup from the brain

The US Food and Drug Administration (FDA) has approved Lecanemab, a breakthrough drug to treat Alzheimer’s, that is manufactured by biotechnology companies Biogen and Eisai.

The drug is an intravenously administered humanized monoclonal antibody that targets amyloid, the toxic protein in the brain linked to the cognitive disease.

Continue reading…

Related posts

10 people dead and 12 injured in school shooting in city of Graz in Austria – Europe live

AEA3

Sturgeon criticised by MSPs over Alex Salmond despite being cleared over ministerial code breach – live

AEA3

‘Worth waiting for’: Jennifer Lopez and Ben Affleck get married in Las Vegas

AEA3

Pin It on Pinterest

Share This